Results 241 to 250 of about 115,457 (286)
Abstract Chronic illness represents a transition for both patients and their family members although transitions and information behavior changes have largely been explored from an individual perspective. Illness‐related transitions may be undertaken individually or collectively, but little is known about how family information networks change in the ...
Lindsay K. Brown, Tiffany C. Veinot
wiley +1 more source
CLSM media file showing the male genitalia of Aulacus burquei, dorsal view (PSUCIM_2359)
István Mikó
openalex +1 more source
ABSTRACT This preregistered study examined whether the gender identity phenotype differs between autistic and non‐autistic children and adolescents, as well as whether gender identity traits aggregate similarly within their families. Study 1 involved four matched groups of autistic and non‐autistic gender diverse youth referred to a UK specialist ...
Matthew C. Fysh +4 more
wiley +1 more source
The Male Genitalia of Blattaria. IV. Blaberidae Blaberinae
Louis M. Roth
doaj +1 more source
ABSTRACT Autism and borderline personality disorder (BPD) are each associated with increased psychiatric emergency department (PsyED) use, yet the service impact of coexisting autism–BPD remains unclear. We conducted a retrospective chart review of 1027 PsyED visits by 345 autistic adults (2018–2020) at an urban Canadian psychiatric hospital to compare
Ching‐Hua Julie Lee +15 more
wiley +1 more source
The Male Genitalia of Blattaria. III. Blaberidae: Zetoborinae
Louis M. Roth
doaj +1 more source
Aims Globally, Australia has the highest per capita consumption rate of pregabalin, commonly prescribed for neuropathic pain. Emerging evidence suggests pregabalin may be associated with the onset or recurrence of several potentially life‐threatening psychiatric events in some individuals.
Amy G. McNeilage +4 more
wiley +1 more source
Aesthetic surgery of the male genitalia. [PDF]
Alter GJ, Salgado CJ, Chim H.
europepmc +1 more source
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon +12 more
wiley +1 more source

